Open AccessDrug Brings Marked Responses in Refractory HER2-Positive Breast Cancer
Author(s) -
Peter M. Goodwin
Publication year - 2020
Publication title -
oncology times
Language(s) - Uncategorized
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000658840.70069.76
Subject(s) - drug , breast cancer , refractory (planetary science) , medicine , oncology , cancer , pharmacology , biology , astrobiology